Literature DB >> 12417029

Two enzyme-linked immunosorbent assay (ELISA) systems for N1,N8-diacetylspermidine and N1,N12-diacetylspermine using monoclonal antibodies.

Masaru Hamaoki1, Kyoko Hiramatsu, Setsuo Suzuki, Atsuo Nagata, Masao Kawakita.   

Abstract

We obtained monoclonal antibodies against N(1),N(12)-diacetylspermine (DiAcSpm) and N(1),N(8)-diacetylspermidine (DiAcSpd), and developed two systems of competitive ELISA that utilize the antibodies and a common enzyme-labeled antigen to measure these di-acetylpolyamines. Cross-reactions with N(1)-acetylspermidine in the assay of DiAcSpm and with N8-acetylspermidine in the assay of DiAcSpd were as low as 0.26 and 0.6%, respectively, and were judged to be insignificant in clinical use for measuring urinary diacetylpolyamines. These assays were used to assess diurnal variations in diacetylpolyamine excretion in urine to show that the excretion of diacetylpolyamines after normalization for the concentration of creatinine is stable over a day with only minimal diurnal variation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417029     DOI: 10.1093/oxfordjournals.jbchem.a003287

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  3 in total

Review 1.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

2.  The clinical usefulness of urinary N(1),N(12)-diacetylspermine (DiAcSpm) levels as a tumor marker in patients with colorectal cancer.

Authors:  Yoshifumi Nakayama; Takayuki Torigoe; Noritaka Minagawa; Koji Yamaguchi
Journal:  Oncol Lett       Date:  2012-02-29       Impact factor: 2.967

3.  Urinary biomarkers of mycobacterial load and treatment response in pulmonary tuberculosis.

Authors:  Qianjing Xia; Myung Hee Lee; Kathleen F Walsh; Kathrine McAulay; James M Bean; Daniel W Fitzgerald; Kathryn M Dupnik; Warren D Johnson; Jean W Pape; Kyu Y Rhee; Flonza Isa
Journal:  JCI Insight       Date:  2020-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.